Tiger Global has led another round for Infra.Market, having done the same six months ago when Sistema Asia Fund also invested.

SoftBank helped the raw materials procurement company secure $160m in a series E round, which will finance its acquisition strategy.

New and returning investors have chipped into the ETH Zurich plant-based meat spinout’s pre-series B round, five months after it completed a series A.

The MDC spinout raised a series B round which will be used to boost its manufacturing capacity and advance its pipeline of candidates.

The developer of T-cell receptor therapies backed by Boehringer Ingelheim raised a series B round which will be used to boost its manufacturing capacity and advance its pipeline of candidates.

The industrial sensor manufacturer spun out of Michigan and Virginia has increased its latest round to $51m in a tranche backed by 3M, Ericsson and Armstrong International.

Corporate-backed teleconferencing system provider Baijiayun raised cash at a $465m valuation while financial software provider Prime Trust closed a $64m round featuring Nationwide and Samsung Next.

UPMC Enterprises has contributed to a $117m series B round for gene therapy developer Ring Therapeutics.

Only five months after closing a $541m series A round, SVolt has closed a $1.58bn series B backed by investors including Xiaomi and Sany.

SoftBank’s Vision Fund returned for the $1bn funding round that valued the personal services platform operator at $15bn.